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A thyroid hormone-regulated gene in Xenopus laevis encodes a type
III iodothyronine 5-deiodinase
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ABSTRACT The type III iodothyronine 5-deiodinase me-
tabolizes thyroxine and 3,5,3'-trilodothyronine to inactive me-
tabolites by catalyzing the removal of iodine from the inner
ring. The enzyme is expressed in a tissue-specific pattern
during particular stages of development in amphibia, birds,
and mammals. Recently, a PCR-based subtractive hybridiza-
tion technique has been used to isolate cDNAs prepared from
Xenopus laevis tadpole tail mRNA that represent genes up-
regulated by thyroid hormone during metamorphosis. Se-
quence analysis ofone of these cDNAs (XL-15) revealed regions
of homology to the mRNA encoding the rat type I (outer ring)
5'-deiodinase, a conserved UGA codon that encodes
selenocysteine in the mammalian enzyme. We report here that
the protein encoded by the XL-15 cDNA efficiently catalyzes the
(inner ring) 5-deiodination of3,5,3'-triiodothyronine with aKm
value of 2 nM and is resistant to inhibition by propylthiouracil
and aurothioglucose. Our analysis confirms that the UGA
codon encodes a selenocysteine that is critical for the catalytic
activity of the enzyme. In addition, the direct induction of
XL-15mRNA levels by thyroid hormone inX. laevis tadpole tail
tissue and cultured ceil lines correlates closely with increases in
5- (but not 5'-) deiodinase activity. These findings indicate that
the XL-15 cDNA encodes a type III 5-deiodinase and under-
scores the importance of the trace element selenium in thyroid
hormone metabolism.
Amphibian metamorphosis requires thyroid hormone (TH)
for the coordinate maturation of a number of organ systems
and metabolic processes (1). Essential to the regulation ofTH
action in both adult and larval forms are the iodothyronine
deiodinases that metabolize TH to active and inactive me-
tabolites (2). The type III 5-deiodinase (SDIII), which cata-
lyzes the removal ofan iodine from the inner ring ofthyroxine
and 3,5,3'-triiodothyronine (T3) to form the inactive metab-
olites 3,3',5'-triiodothyronine (rT3) and 3,3'-diiodothyronine,
respectively, has been postulated to play a protective role in
selected tissues by preventing their exposure to inappropri-
ately timed or excessive levels of active TH (3). This enzyme
is expressed in a tissue-specific pattern during particular
stages of fetal growth in amphibia, birds, and mammals,
suggesting that it plays an important role in coordinating the
developmental effects of TH (1, 4-6).
Little is known about the biochemical characteristics ofthe
5DIII or the mechanism of its regulation during development
because, like the other deiodinases, it has yet to be purified,
and cDNAs for the enzyme have not been isolated. Recently,
the type I 5'-deiodinase (outer ring, 5'DI) was demonstrated
to be a selenoprotein and to contain selenocysteine at its
catalytically active site (7). Results of site-directed mutagen-
esis studies of the 5'DI suggest that the presence of the
selenocysteine renders the enzyme sensitive to inhibition by
6n-propyl-2-thiouracil (PTU) and aurothioglucose (AThG)
(8). Based on this and other evidence, the SDIII and the type
II S'-deiodinase, both of which are insensitive to PTU and
AThG inhibition, have been assumed to be unrelated struc-
turally to the 5'DI and to not contain selenocysteine (9-11).
In Xenopus laevis, TH has been demonstrated to alter
directly the expression of a number of genes involved in
programmed metamorphosis (12, 13). A subset ofthese genes
are up-regulated rapidly in X. laevis tadpoles after the ad-
ministration ofT3 (13). We report here the characterization of
the protein product ofone such early response gene (XL-15)§
(13). We demonstrate that this gene product, which is a
selenoprotein bearing significant sequence homology to the
mammalian S'DI, is the enzyme SDIII.
MATERIALS AND METHODS
Isolation and Sequencing of the XL-15 cDNA. The XL-15
(gene 15) cDNA was isolated as described (13) from a
directionally cloned A phage cDNA library prepared from X.
laevis tail mRNA (ZapII; Stratagene) using a probe obtained
from a PCR-based cDNA fragment library (14). The cDNA
was sequenced on both strands using nested deletions (Erase-
a-Base system; Promega) and an automated sequencing sys-
tem using fluorescent dye terminators (Applied Biosystems).
Expression of XL-15 in X. laevis Oocytes. Stage 5 to 6 X.
laevis oocytes were microinjected with in vitro-synthesized,
capped RNA transcripts in amounts that maximized deiodi-
nase expression (XL-15 transcripts at 10 ng per oocyte, rat
G21 5'DI mRNA at 1 ng per oocyte), and incubated for 4 days
in L-15 medium [for determination of 5'-deiodinase (5'D)
activity] or Barth's medium [for determination of 5-deiodi-
nase (SD) activity]. Oocytes were then harvested, membrane
fractions were prepared as described (15), and deiodinase
activity was determined according to published methods (15,
16). In kinetic studies, 5'D activity was determined using
1.5-1000 nM [1251]rT3 as substrate and 20 mM dithiothreitol
as cofactor, and 5D activity was determined using by 1-20nM
[125I]T3 and 50 mM dithiothreitol. Kinetic constants were
determined from Eadie-Hofstee plots. In some experiments,
glutathione (5 or 50 mM) or a reconstituted thioredoxin
system consisting of thioredoxin (42 gM final concentration;
Calbiochem), thioredoxin reductase (42 nM; provided by
James A. Fuchs, University of Minnesota), and NADPH (0.5
mM) were used as cofactors in the deiodination assays.
[125I]iodothyronines used as substrates were obtained from
DuPont and were purified by chromatography using Sepha-
dex LH-20 (Sigma) before use.
Abbreviations: AThG, aurothioglucose; PTU, 6n-propyl-2-
thiouracil; rT3, 3,3',5'-triiodothyronine; TH, thyroid hormone; T3,
3,5,3'-triiodothyronine; 5D, 5-deiodinase; 5'D, 5'-deiodinase; 5DIII,
type III 5-deiodinase; Y'DI, type I 5'-deiodinase.
The sequence reported in this paper has been deposited in the
GenBank data base (accession no. L28111).
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In other experiments, the induced XL-15 and G21 deiodi-
nase activities in oocyte membrane preparations were deter-
mined in the absence or presence of PTU (10-1000 1A) or
AThG (0.01-10 ,uM). 5'D activity was measured using 67 nM
[125I]rT3 as substrate and 20 mM dithiothreitol as cofactor.
The 5D assay used 1 nM [125I]T3 and 50 mM dithiothreitol.
Proteins were determined by the method of Bradford (17)
with reagents obtained from Bio-Rad. The G21 cDNA was
provided by M. Berry and P. R. Larsen (Brigham and Wo-
men's Hospital, Boston).
Functional Analysis of the XL-15 cDNA by Mutation and
Deletion. Site-directed mutagenesis was done by using the
Altered Sites mutagenesis system according to the manufac-
turer's instructions (Promega). Partial deletions of the 3'-
untranslated region were prepared using the XL-15 cDNA
cloned into the Bluescript vector. XL-15/Bluescript plasmids
were isolated from transformed Escherichia coli and digested
with Xho I and Kpn I. The 3'-untranslated region of the
cDNA insert was subjected to exonuclease III digestion for
various periods of time followed by S1 nuclease treatment.
Plasmids were then recircularized using Klenow and T4DNA
ligase and used to transform bacteria. All procedures were
done according to the manufacturer's instructions (Erase-a-
Base system; Promega). Plasmids containing the deletion
mutants were then subjected to PCR using the Bluescript
forward and reverse sequencing primers. The PCR products,
containing the T3 RNA polymerase promoter site upstream
from the cDNA inserts, were then used for the synthesis in
vitro ofcapped RNA transcripts. All mutations and deletions
were confirmed by sequence analysis. For each construct,
oocytes were injected with 50 ng of RNA transcripts and 4
days later5D and 5'D activities were determined as described
above. Activity was compared with that obtained in oocytes
injected with an equivalent amount ofRNA synthesized from
the wild-type cDNA in either the pAlter vector (for muta-
tional analysis) or Bluescript (for deletional analysis).
Animal Experiments. X. laevis tadpoles were maintained in
deionized water. Developmental stages were determined
according to Nieuwkoop and Faber (18). Tails were obtained
from stage 54, 60, and 63 tadpoles, some of which had been
injected with T3 (1 nmol/g of body weight, i.p.) 2-4 days
before sacrifice. Tissue was homogenized in 3 vol of 0.25 M
sucrose/0.02 M Tris-HCI, pH 7.6, for determination of 5D
activity or 0.25 M sucrose/0.02 M Tris HCI, pH 7.0/1 mM
EDTA for determination of 5'D activity. Assays were done
as described above, except that the 5'D assay used 1.5 nM
[125I]rT3 as substrate. The 50-A reaction mixture contained
10-50 pg of tail homogenate protein.
Cell Culture Experiments. Cultured XTC, XLA, and XL58
X. laevis cells were grown and maintained as desciibed in
70% (vol/vol) Leibovitz medium/10%o (vol/vol) fetal bovine
serum (GIBCO/BRL) that had been depleted of TH by
incubation with AG1-X8 resin (Bio-Rad) (19), gentamycin
sulfate (100 pg/ml), and 10 mM Hepes (pH 7.5) at 25°C (20).
1 CGGAGGGGGTGAGGGCTGAGCACCATGTTGCACTGCGCGGGACCCCACACCGGTAAACTT
61 GTGAAACAGGTGGCCGCCTGCTGCCTGCTGCTGCCCCGCTTCCTGCTCACGGGGCTGATG
121 CTGTGGCTGCTGGATTTCCAGTGTATCAGGAGGAGGGTCCTGTGACCGCCAGGGAGGAGA
181 GCACCGCCGAGCACGAAGACCCCCCGCTGTGCGTGTCCGACTCCAACCGAATGTGCACCG
M C T V
241 TGGAGTCGCTGCGAGCCGTGTGGCACGGGCAGAAGCTGGACTACTTCAAGTCGCGCACC
E S L R A V W H G Q K L D Y F K S A H L
301 GGGCTGCTCGGCGCCCAACACGG GA GAAGGGCGCAGGCTGTGCAAG
GC S A P T E Y Id E G R R L £ K I
361 TCCTGGACTTCTCCCAGGGCAAGAGACCGCTGGTTGTCAATTTCGGCAGCTGCACCTGAC
L 2 F S Q Q K B P LSV u F a g Z I U P
421 CCCCGTATGGCTCGCCTGCAAGCCTATCGCCGCCTGGCAGCCCAGCACGTTGGCATCa
P E M A R L Q A Y R B L A A Q H V G I _
481 CGGATTTCCTGCGGTGTACATAGAAGAAGCGCACCCGTCAGACGGCTGGCTCAGCACCG
F L L V Y P S D L S T D
541
LZj&1 Qk
541 ACGCCTCCTACCAAATCCCCCAGCACCAGGCCTGCAGGACCGCCTGGCCGCGGCTCAGC
A S Y Q I P Q C I Q D a L A A A Q
601 TC-ATG=CCAAGGGGCG GCTGCCGGGTGGTGGTGGACACCATGGACAATCCTCCA
M Q G A I G £ R Y Y Y P T D S N
661 ACGCCGCCTACGGTGCCTACTTTGAGAGACTTTACATCGTCCTGGAGGGCAAAGTGGTG
A A I G A Y F P a L Y I V L E K V V Y
721 ACCAGGGGGGTCGGGGGCCGGAGGGCTACAAGATCTCTGAATGAGGATGTGGCTGGCAGC
Q Q G R G P E G X K I S F L I M W I F Q
781 AGTACCAGCAGGGCTTGATGGGGACCAAGGGCAGCGGCCAAGTGGTCATTCAAGTGTAAT
Y Q Q G L M G T K G S G Q V V I Q V *
841 TGTCATCAGCAGCAGCAGCACCAAGGCAACGGGACACAATAACCACCACCAGCAGCAGCA
901 GCAGTATTATTACTATTGTTATTATTATTGTCATTATTATAGAGGCAGGTGGAACCTGTT
961 AGGTGAAGTGACTGAAAGTACACAAAAAGTGCGACCAAACGACTCCTTTCTTTAAATCCC
1021 AGTGCGACAAATAGTAGTAAACTGCAACAAGGGAAAGGCATCCCATCTGCGCACCTCGGG
1081 CTCAATCGCAACTTCCAACACGTCCAGTCCCCCCGACTCATCAGGGAGTTGCCATTGAAC
1141 AAATGCCGGAGGGTCGCGGTTCAGATGTCATTGCGAGAATAATAAGCTACAGTGGCTGTC
1201 TGTCTGTCCCCAGCTGTGTGTGCGACTAAGCCGCTGTGTGAAGTGGGGCGGGAGTACAAG
1261 GTGCGTGTGACTGGAGCCACCCACTCCGACTCTGCAGGTGTTTGCTAAT GACACGAT
1321 TTGAAATGGTCTCACGGCCA TCGTGTCCGACATCAACCCCCTTCCTCAAACTACC
1381 TGCAGGCTCCGGTGTCGGGCTCCTCCAGTCCAGTAGATTTATTTATGTGATTTTTGTAAG
1441 CAGACTTTTATATAAAGGATTTTTTACGATTAAAAACATGACCACATAAAAAAAAAAAAA
1501 AAAAAAAAAA
FIG. 1. Nucleotide and deduced amino acid sequence of the XL-15 cDNA. Underlined nucleotide sequences in the open reading frame
represent five regions with significant homology to the rat G21 S'DI cDNA (7). Underlined amino acid residues have been conserved between
the XL-15 and G21 proteins. The underlined nucleotides in the 3'-untranslated region between 1306 and 1351 are similar to the selenocysteine
insertion element required to translate the UGA codon into a selenocysteine residue (22). The double-underlined nucleotides are identical to
the eukaryotic consensus sequences of this element (22).
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Cells were treated with 5 nM T3 for 48 hr before harvesting.
For Northern analysis, RNA was extracted from cells, elec-
trophoresed, blotted, and probed as described (20). For
deiodinase determinations, cells were harvested, washed,
and sonicated according to published methods (21). Protein
concentrations in the sonicated preparations were 14.1-15.2
mg/ml. 5D and 5'D activities were assayed as described
above using undiluted cell sonicates or dilutions of the
sonicates of 1:5 to 1:200 depending on the relative amount of
activity. XTC and XL-58 cells were from I. Dawid (National
Institutes of Health) and R. Steele (University of California,
Irvine), respectively.
RESULTS
The nucleotide sequence ofthe 1.5-kb X. laevis XL-15 cDNA
is shown in Fig. 1. Comparison of this sequence with that of
the rat G21 5'DI cDNA isolated by Berry et al. (7) reveals five
regions with 53-75% nucleotide identity. The first region
contains an in-frame TGA triplet which in the G21 cDNA
encodes for selenocysteine. Assuming a similar function for
this codon in XL-15, an open reading frame of606 nt encoding
a protein of 202 amino acids with a molecular mass of 22 kDa
is predicted from the sequence. Amino acid conservation
with the G21-encoded protein within the 162-residue central
region of the XL-15 protein is 50%, including two histidine
residues encoded by codons at nt 513 and 564. These his-
tidines have been shown previously to be critical for the
activity of the rat 5'DI (23). Nucleotide sequences within the
3'-untranslated region of XL-15 (nt 1306-1351) are similar to
consensus sequences required in eukaryotes to translate the
UGA codon with the amino acid selenocysteine (22).
The protein encoded by XL-15 was characterized by
expression in X. laevis oocytes. The 5'DI encoded by the G21
cDNA was expressed in other oocytes in the same experi-
ments, so that the properties of these two proteins could be
compared directly. Results of kinetic analyses of the ex-
pressed activities are shown in Table 1. As we and others
have demonstrated previously, the injection into oocytes of
G21-derived RNA transcripts induces 5'D activity with a Km
value for rT3 of 0.1-0.2 ,uM when assayed in the presence of
5-20 mM dithiothreitol (7, 15). No SD activity was detected
in these oocytes when T3 was used as substrate. In contrast,
oocytes injected with XL-15-derived RNA transcripts con-
tained abundant SD activity with a Km for T3 of 2 nM.
Maximal SD activity was noted at a dithiothreitol concentra-
tion of 200 mM, whereas 5 or 50 mM glutathione did not
stimulate SD activity (data not shown). Although 5'D activity
could also be demonstrated in concentrated microsomal
preparations from these oocytes, this reaction was catalyzed
much less efficiently than 5-deiodination, as reflected by the
700-fold greater value of the Vmax/Km ratio for the latter
process. Unlike the G21-derived 5'DI (15), glutathione (5 or
50 mM) or a reconstituted thioredoxin cofactor system did
not support a significant level of 5'-deiodination by the
XL-15-encoded deiodinase (data not shown).
The sensitivity ofthe G21- and XL-15-encoded deiodinases
to inhibition by PTU and AThG was compared. As shown in
Fig. 2, and consistent with previous studies by Berry et al.
Table 1. G21- and XL-15-encoded expression of deiodinase
activity in X. laevis oocyte membranes
cDNA Activity Kmi, M Vma.* units Vmsc/Km
G21 5' 0.18 12.1 66.3
G21 5 No activity detected
XL-15 5' 0.44 0.5 1.2
XL-15 5 0.002 1.3 727.0
In two additional experiments, similar kinetic data were obtained.
*Units = pmol/min-mg of protein.
A G21 XL-15 XL-15
c120 5'D Activity 5'D Activity 5D Activity
o120
opl80M
40-
0
0
101000101001000 10 010
Propyithiouracil, ~iM
B G21 XL-15 XL-15
5'D Act ivitv -' nr Activitv .C n Artivitv
120 B
o 80
.
40 1-. l U
01
.1 1 l .01O
1 1
u0or 1 1 1Aurothioglucose, AMFIG. 2. Effects of deiodinase inhibitors on expressed SD and 5'D
activities in X. laevis oocytes. (A) Effect of PTU on XL-15- and
G21-encoded activities. (B) Effect of AThG on XL-15- and G21-
encoded activities. Single assays were done for each data point.
Control incubations in the absence of inhibitors were done in
duplicate with a coefficient of variation of <5%. Essentially identical
results with both compounds were obtained in a second experiment.
(7), the G21-encoded 5'D activity was sensitive to inhibition
by these two compounds, a property demonstrated to require
a selenocysteine residue at the active site of the enzyme (8).
In contrast, the XL-15-encoded enzyme was resistant to
inhibition by these agents; as compared with the G21-
expressed activity, 100-fold or greater concentrations of the
two compounds were required to inhibit both SD and S'D
activities in membranes prepared from XL-15-injected
oocytes.
This resistance of the XL-1S deiodinase to inhibition by
PTU and AThG raised the possibility that the encoded
protein is not a selenoprotein or that selenocysteine is not
involved in the catalytic activity. To investigate this further,
site-directed mutagenesis of the XL-1S cDNA was done to
alter the presumed selenocysteine-encoding TGA codon to
another stop codon (TAA) or one encoding leucine (TTA) or
cysteine (TGT). Fig. 3 shows complete loss of both SD and
5'D activity with the stop and leucine mutant constructs. The
cysteine mutant retained -24% of the wild-type 5D activity,
but no S'D activity could be demonstrated, further empha-
sizing that the XL-15-encoded deiodinase is primarily an
inner ring deiodinase. Deletion analysis of sequences in the
3'-untranslated region demonstrated that nt 1187-1382,
which include the putative selenocysteine insertion element,
are necessary for the expression of a functional deiodinase
(Fig. 3).
Confirmation of the identity and physiological significance
of the XL-15 deiodinase was sought by comparing the levels
of 5D and 5'D activity with the patterns of expression of the
XL-1S mRNA in the tail from control and T3-treated X. laevis
tadpoles and in several X. laevis cell lines, cultured with and
without T3. As shown in Fig. 4, SD activity in the tail from
tadpoles not exposed to T3 increased as tadpoles progressed
Developmental Biology: St. Germain et al.
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Mutants
TGA _ 1487
ATG TM SECIS
TM
TTA
TGT
TGA _1382
TGA
I
TGA
1187
1041
TGA 841
1 -r~~~~~
Relative Activity
5100 51-D
100% 100%
A
XTC
T3 l +
XLA XL58
Irz 1 I 4-1
0 0
0 0
24% 0
83% ND
0 ND
0 ND
0 ND
FIG. 3. Effects of UGA codon mutations and progressive dele-
tions of the 3'-untranslated region of the XL-15 cDNA on expressed
5D and 5'D activities inX. laevis oocytes. Values represent the mean
of the results of two experiments that agreed closely. SECIS,
selenocysteine insertion sequences; ND, not determined.
from stage 54 (premetamorphosis) to stage 60 (climax) and
then declined at stage 63. This pattern is identical to that
previously noted for the expression of XL-1S mRNA in the
tail (13). The marked stimulation of SD activity by T3 in tail
from stage 54 tadpoles is also consistent with previous
observations showing rapid up-regulation ofthe mRNA by T3
(13). In contrast, S'D activity differed little in tail tissue from
stage 54 and 60 tadpoles and was not stimulated by T3 at stage
54 (Fig. 4), suggesting that this activity was catalyzed by a
different deiodinase. Consistent with this thesis, the Km value
for 'D activity in stage 60 tadpole tail homogenates using rT3
as substrate was 35 nM, a value markedly lower than that
induced in oocytes by the injection of XL-15 transcripts
(Table 1). The inclusion ofPTU (100 AtM) in tail homogenates
did not inhibit either 5- or 5'-deiodination (data not shown),
indicating that activity typical of the 5'DI was not present.
The expression of XL-15 mRNA differed considerably in
three X. Iaevis cultured cell lines (Fig. SA). Basal expression
ofmRNA is exceedingly low in XTC cells, but it was induced
markedly after exposure for 48 hr to 5 nM T3. This induction
is resistant to inhibitors of protein synthesis, indicating that
up-regulation of the XL-15 gene in XTC cells is a direct
response to TH (A.K. and D.D.B., unpublished observa-
tion). XLA cells contain a relatively high basal level ofXL-15
5-Deiodination
6
63
25 -
a) 20
a5 a 15 - la.
0E
> E
~ 0
05
T3 - + - +
54 60
Stage
5'-Deiodination
F25
-20
~-10>=
54 60
Stage
FIG. 4. SD and 5'D activity in stage 54, 60, and 63 X. Iaevis
tadpoles tail tissue untreated (-) or pretreated (+) with T3. Points
represent separate homogenate preparations.
B
50 - 5-Deiodination
*c 40-
-0 2
E 10
T3 - + - + - +
XTC XLA XL58
Cell Line
C
I.u b
-ueiodinatlon
0.8-
w *c: 0.4-6
E 0.2
0
T3 - + - + -
XTC XLA XL58
Cell Line
FIG. 5. Relative levels ofXL-15 mRNA and deiodinase activities
inX. laevis cultured cell lines. (A) Northern analysis ofXL-15 mRNA
in cultured cell lines treated with (+) and without (-) T3. (B) 5D
activity in cultured cells treated with (+) and without (-) T3. (C) 5'D
activity in cultured cells treated with (+) and without (-) T3. Each
bar represents the result of a single determination. Essentially
identical results were obtained in a second experiment.
mRNA, which increases further after T3 treatment. XLS8
cells exhibit yet a third pattern ofXL-1S expression; the level
ofmRNA is undetectable in the basal state and is unaffected
by T3. The pattern ofSD activity in these cell lines is identical
to that of XL-15 mRNA expression, whereas the pattern of
5'D activity is not (Fig. S B and C). Furthermore, the Km
value for T3 of the SD activity in the XTC and XLA cell lines
is 3 nM, providing further evidence that it is encoded by the
XL-15 gene. It is notable that the XLS8 cells, which exhibit
no detectable XL-15 mRNA, contain significant amounts of
a S'D activity (Fig. 5C), which manifested a relatively lowKm
when rT3 was used as substrate (24 nM), suggesting, as in the
case ofthe tadpole tail, that this outer ring activity is encoded
by a gene other than XL-1S. PIU (100 A.M) did not inhibit
either SD and S'D activity in any of the cultured cell extracts
(data not shown).
DISCUSSION
These studies show that the XL-1S cDNA encodes a deio-
dinase that differs markedly in properties from the G21-
encoded rat S'DI, despite the similarities in their sequences-
including the presence of selenocysteine. Indeed, the XL-1S
enzyme possesses all the characteristics ofa SDH, including
a Km value in the nanomolar range for T3, requirements- for
SeCys
Stop
Leu
Cys
Deletion
1
Deletion
2
Deletion
3
Deletion
4
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relatively high dithiothreitol concentrations, and insensitivity
to inhibition by PTU and AThG (11, 24). It thus represents the
only cDNA isolated for this class of deiodinases and the only
nonmammalian deiodinase cDNA to be characterized. The
finding that the XL-15-encoded deiodinase also catalyzes
5'-deiodination, although at a considerably lower catalytic
efficiency, is unexpected. The properties of this 5'D activity
(high Km for rT3 and resistance to inhibition by PTU and
AThG) are remarkably similar to those recently described for
an unusual 5'D activity found in the kidney of a teleost fish
(tilapia) (25). Unfortunately, the presence or absence of SD
activity in the tilapia kidney was not reported.
The close correlation in the patterns of expression of
XL-15 mRNA and SD activity in X. laevis tail and cultured
cells lends further support to the conclusion that this cDNA
encodes the SDIII. In this regard, a notable property of the
XL-15 gene is that it is markedly and rapidly induced by T3
before metamorphic climax (13), a feature consistent with
the postulated protective role of the SDIII during develop-
ment. The finding that exogenous T3 does not stimulate
XL-15 expression during metamorphic climax in X. laevis
(stages 60 and 63) is likely due to the fact that this and other
T3-responsive genes are already fully induced by the high
levels ofendogenous hormone present at these stages. This
has been shown to be the case in Rana catesbeiana tadpoles
(26). Both X. laevis tadpole tail and cultured cells were
noted in these studies to express a 5'D activity the char-
acteristics of which (insensitivity to PTU and Km value in
the nanomolar range using rT3 and dithiothreitol as sub-
strate and cofactor, respectively) match most closely those
of the mammalian type II 5'D (24). These findings are
analogous to those reported (1) in R. catesbeiana tadpoles,
where only types II and III deiodinase activities have been
described.
These studies demonstrate that, like the G21-encoded S'DI
(7), selenocysteine is critical for the catalytic activity of the
XL-15-encoded enzyme, a finding consistent with the signif-
icant nucleotide and amino acid conservation surrounding the
selenocysteine codons in these proteins. However, given that
the sensitivity of the mammalian S'DI to PTU and AThG has
been attributed to the presence of selenocysteine at its active
site (8), it is surprising that the XL-15-encoded 5DIII contains
this uncommon amino acid. This result indicates that factors
in addition to the presence of selenocysteine can influence
sensitivity of the enzyme to inhibition by these compounds.
As a corollary, resistance to PTU and AThG cannot be used
as a criterion to exclude the presence of selenocysteine in
deiodinase enzymes, raising the possibility that as-yet-
uncharacterized deiodinases (such as the type II or mamma-
lian type III) may also be selenoproteins.
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